If you’re trying to prove a tool is working, or trying to figure out if the one you have is worth renewing, the revenue cycle performance metrics that matter split into three categories: 1) what $$ came back, 2) what it cost to get it back, and 3) whether the work itself actually changed.
Recovery
Not just what was found, but what actually came back.
- Net recovery rate. Dollars actually posted to AR divided by dollars a tool flagged as recoverable.
- First-pass resolution rate on flagged claims. Of the claims a tool prioritizes, what share resolve without a second touch, resubmission, or appeal. This is the number that tells you if prioritization logic is any good.
- Overturn rate on tool-recommended appeals. For claims the tool specifically routes to appeal, what percentage actually get overturned by the payer. A tool that drives appeal volume without moving this number is generating work, not recovery.
- Recovery velocity. Days from flag to payment, not days from flag to “worked.” A $40K underpayment your team hasn’t collected in 90 days isn’t $40K of value yet. It’s a line item.
Cost
- Cost-to-collect per recovered dollar. Labor plus tool cost, divided by dollars actually recovered.
- FTE hours per resolved claim, before and after. A tool that adds a queue for staff to check without reducing the hours spent per resolution isn’t cutting cost. It’s adding a step.
- Appeal win rate against appeal volume. Track these together. Filing more appeals looks productive right up until win rate drops, which usually means the tool is optimizing for activity instead of accuracy.
Workflow
- Touches per claim. If this number doesn’t move after implementation, the tool improved your reporting, not your workflow.
- Work list precision. The percentage of claims placed in a workqueue that are actually worth staff time. A queue padded with low-value claims inflates activity metrics while burning capacity.
- Aging distribution shift, not aggregate AR reduction. Whether claims are moving out of 90+ day buckets faster. Total dollars in AR can drop from write-offs alone, which looks like progress and isn’t.
None of this is clean in practice. If your EHR, clearinghouse, and RCM tool all touch the same claim before it resolves, isolating one vendor’s specific contribution is hard. The more honest approach is a 60- to 90-day pre-implementation baseline, held against payer mix and volume, so you’re comparing the same conditions on both sides.
This is part of why we built RevProtect’s recovery reporting around net recovery by payer instead of aggregate identified value.
If you’re evaluating a tool, or defending the ROI of one you already run, pull these revenue cycle performance metrics for a single payer over a single quarter before you pull them across your whole mix. The math holds up better at that scale, and it’ll tell you faster whether what you’re looking at is recovery or just a very well-organized list.
